Navigation Links


Tag: "tratuzumab" at medical news

Combination of Tratuzumab and Chemotherapy Yields Better Results for Breast Cancer

A recent meta-analysis of five major breast cancer trials has confirmed that combination treatment with the antibody trastuzumab and chemotherapy improves survival in women with operable HER-2 positive breast cancer. ......At the ESMO Conference Lugano, Issa Dahabreh from the University of Athens reported the results of a meta-analysis of 5 trials involving more than 13,000 women whose breast c...
Other Tagsstrains 2strains 3strains 4strains 5strains 6strains 7strains 8strains 9strains 10later 2later 3later 4later 5later 6later 7later 8later 9later 10prevents 2prevents 3prevents 4prevents 5prevents 6prevents 7prevents 8prevents 9prevents 10that 2that 3that 4that 5that 6that 7that 8that 9that 10wrongly 2wrongly 3positively 2adults 2adults 3adults 4adults 5adults 6adults 7adults 8adults 9adults 10supports 2supports 3supports 4supports 5supports 6supports 7
(Date:12/16/2009)... -- Allscripts (Nasdaq: MDRX ) announced today ... the three and six months ended November 30, ... January 11, 2010. Allscripts management will host a ... earnings and other information at 8:30 AM Eastern ... http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO ) ,, Allscripts fiscal second quarter ...
(Date:12/16/2009)... Mich., Dec. 16 The most widely used human ... that raises social justice questions that must be addressed ... stem cell advances, according to a University of Michigan ... its kind, the U-M team analyzed 47 embryonic stem ... by stem cell researchers. The scientists determined the genetic ...
(Date:12/16/2009)... Institute will sponsor a new learning collaborative ... who serve individuals at risk of, or ... plan, medical home and other provider settings. ... webinars on topics, solutions and case studies ... improvement. Each webinar will include a brief ...
(Date:12/16/2009)... susceptibility to disease , , WEDNESDAY, Dec. 16 (HealthDay ... to leprosy have been identified by scientists in ... more than 10,000 DNA samples from leprosy patients ... highlights the important role that the innate immune ... "Though leprosy is not common, the discoveries have ...
(Date:12/16/2009)... Wellcome Trust Sanger Institute announce the first comprehensive analyses ... by mutations in the DNA of cancer cells which ... a malignant melanoma and a lung cancer, reveal for ... genomes of two cancers. , Lung cancer causes around ... associated with smoking. The number of mutations found suggest ...
Breaking Medicine News(10 mins):Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 2Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 3Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 4Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 2Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 3Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 4Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 5Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 2Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 3Health News:Leprosy Genes Identified 2Health News:Lung cancer and melanoma laid bare 2Health News:Lung cancer and melanoma laid bare 3Health News:Lung cancer and melanoma laid bare 4Health News:Lung cancer and melanoma laid bare 5Health News:Lung cancer and melanoma laid bare 6
(Date:12/16/2009)... inhabited our planet for more than 4 billion years ... by as many eons more. That suggests they may ... Tel Aviv University bacteria expert Prof. Eshel Ben-Jacob of ... Astronomy, grounded in the study of bacteria, presents compelling ... most people should not automatically opt for the swine ...
(Date:12/16/2009)... NEW YORK, Dec. 1 iQor, a global ... in the 2009 InfoWorld 100 Awards Top ... system, TeQ21. This was the first submission for iQor. ... prestigious list of companies," said Vikas Kapoor, president and ... we do business, allowing us to work faster, smarter ...
(Date:12/16/2009)... Fla., Dec. 2 Communication Intelligence ... leading supplier of electronic signature solutions for ... and the recognized leader** in biometric signature ... leading International Electronic Document Management (EDM) software ... an agreement to provide their products and ...
Breaking Biology News(10 mins):Bacteria wouldn't opt for a swine flu shot 2Bacteria wouldn't opt for a swine flu shot 3iQor Named to InfoWorld 100 List of Top IT Projects of 2009 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 4Pittsburgh Life Sciences Greenhouse Demonstrates a Regions Economic Resilience 14229 1Pittsburgh Life Sciences Greenhouse Demonstrates a Regions Economic Resilience 14229 2Pittsburgh Life Sciences Greenhouse Demonstrates a Regions Economic Resilience 14229 3MO BIO Laboratories Inc Launches PowerWater 28R 29 RNA Isolation Kit 14226 1MO BIO Laboratories Inc Launches PowerWater 28R 29 RNA Isolation Kit 14226 2Sangamo BioSciences Announces Plans to Initiate a Second Clinical Trial of CCR5 ZFP Therapeutic to Treat HIV AIDS 5037 1Sangamo BioSciences Announces Plans to Initiate a Second Clinical Trial of CCR5 ZFP Therapeutic to Treat HIV AIDS 5037 2Sangamo BioSciences Announces Plans to Initiate a Second Clinical Trial of CCR5 ZFP Therapeutic to Treat HIV AIDS 5037 3Sangamo BioSciences Announces Plans to Initiate a Second Clinical Trial of CCR5 ZFP Therapeutic to Treat HIV AIDS 5037 4Sangamo BioSciences Announces Plans to Initiate a Second Clinical Trial of CCR5 ZFP Therapeutic to Treat HIV AIDS 5037 5Sangamo BioSciences Announces Plans to Initiate a Second Clinical Trial of CCR5 ZFP Therapeutic to Treat HIV AIDS 5037 6
Other Contentssyrupsyrupsyrupmaplemastitismarijuanamarijuanamarijuanamastectomymastectomymedialmedialmedialmedialmedialmastoid